Videos

Witnesses testified at a Senate Caucus on International Narcotics Control hearing on prescription drug abuse and its role in the increased use of Heroin in the U.S. They also spoke about how…

Drug policy and enforcement officials testified on the dangers of using synthetic drugs, such as Molly, K2, Spice, and “bath salts.” Topics included how these drug traffickers could be caugh…

Officials from the Drug Enforcement Administration, Centers for Medicare and Medicaid Services, and Health and Human Services Department testified on prescription drug abuse in the Medicare …

Witnesses testified on measures taken by the federal government, the states, and the private sector to prevent leaks from the supply chain that allow prescription drugs to be diverted to ill…

Witnesses at hearing titled, “Body Building Products and Hidden Steroids: Enforcement Barriers,” focused on body-building supplements marketed to consumers as over-the-counter dietary supple…

A hearing was held to examine the increasing use of prescription controlled substances by teenagers and others for non-medical purposes, which has been exacerbated by the ease of obtaining t…

The witnesses testified about the Food and Drug Administration’s proposed electronic system for prescribing controlled substances. Federal regulators and health information technology analys…

Representatives of the Drug Enforcement Administration, the White House, the pharmaceutical industry, and others talked about prescription drug abuse. Topics included “diversion” of pharmace…

Witnesses testified about operations of unregistered Internet pharmacies and regulating the sale of controlled substances without valid prescriptions. Among the topics they addressed were dr…

Witnesses testified about prescription drug abuse, access to prescription drugs through physicians, the Internet, and patients, as well as the extent of the problem in the U.S. They also tal…

The committee held a hearing to evaluate the administration’s first Synthetic Drug Control Strategy, which was released on June 1, 2006, by the White House Office of National Drug Control Po…